What happened in this episode?
Thomas DeLauer reviews what he describes as unusually strong results from a small dietary intervention study in adults with obesity and metabolic syndrome who had confirmed fatty liver. He says the paper (which he attributes to the Journal of Medicinal Food) tested a “Spanish low-carb Mediterranean diet” over 12 weeks and, as he recounts it, reported high rates of fatty liver improvement and that all participants were no longer classified as having metabolic syndrome by the study’s end, despite remaining overweight.
After an omitted sponsor segment, DeLauer breaks down the diet’s composition: lower carbohydrates within a Mediterranean framework, heavy use of extra-virgin olive oil as the primary fat, and protein centred on poultry and fish, with additional eggs and dairy. He argues olive oil’s monounsaturated fats and polyphenols may support inflammation-related pathways implicated in insulin resistance and liver fat, and he cites a triglyceride drop he says was observed in the study.
He also introduces the “protein leverage hypothesis” as an explanatory model for adherence and reduced energy intake, suggesting people may keep eating until protein needs are met. DeLauer recommends “front-loading” protein earlier in the day and provides practical food examples (fish, eggs, Greek yoghurt, aged cheeses, vegetables, some berries and citrus), along with walking and resistance training. He flags that the evidence he is discussing comes from a pilot study but says the magnitude across biomarkers makes it difficult to dismiss.
